Rosetta is molecular modeling software that has been developed for the prediction and design of macromolecular structure. Rosetta has performed well in community wide assessments of protein structure prediction and docking, and it has been used to engineer proteins for a variety of applications including: scaffold design for vaccine development, biosensor design for live cell imaging, and protein interface design to create inhibitors of human pathogens. Rosetta is developed and maintained by research groups at over 20 universities, and over the 9 years since its first release, 9750 academic laboratories have obtained free licenses to use the software. This proposal is a competing renewal and is in response to a program announcement (PAR-11-028) for the continued development and maintenance of software. Activities from the previous funding periods have been instrumental in the productive growth of Rosetta, these include the creation of a C++ object-oriented version of Rosetta (from Fortran) that allows scientists to more easily combine alternate sampling protocols and energy functions, the development of an automated testing system for checking the integrity of the code base, deployment of web servers for more standard Rosetta simulations, and user support through an online forum system. With this proposal our goal is to further increase the usefulness of Rosetta to expert and non-expert users as well as promote the rapid development of new algorithms by maintaining a robust code base and a rigorous set of technical and scientific benchmarks.
Our specific aims i nclude the further development and extension of scripting tools for generating custom protocols, increasing the speed of Rosetta simulations through parallel computing, deployment of new automated tests to validate code accuracy and enforce coding standards, and user support through a unified web server for Rosetta applications.

Public Health Relevance

The function of a protein, RNA or DNA molecule is largely determined by its 3-dimensional structure. We aim to develop a state-of-the-art computer program for predicting and designing the structures of biological macromolecules. The program will be freely available to academic laboratories and its predictions will help investigators understand and fight human diseases such as cancer and AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM073151-09
Application #
8729395
Study Section
Biodata Management and Analysis Study Section (BDMA)
Program Officer
Friedman, Fred K
Project Start
2005-03-01
Project End
2017-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
9
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bornhop, Darryl J; Kammer, Michael N; Kussrow, Amanda et al. (2016) Origin and prediction of free-solution interaction studies performed label-free. Proc Natl Acad Sci U S A 113:E1595-604
Gajewski, Stefan; Waddell, Michael Brett; Vaithiyalingam, Sivaraja et al. (2016) Structure and mechanism of the phage T4 recombination mediator protein UvsY. Proc Natl Acad Sci U S A 113:3275-80
Konduri, Kartik; Gallant, Jean-Nicolas; Chae, Young Kwang et al. (2016) EGFR Fusions as Novel Therapeutic Targets in Lung Cancer. Cancer Discov 6:601-11
Li, Bian; Mendenhall, Jeffrey; Nguyen, Elizabeth Dong et al. (2016) Accurate Prediction of Contact Numbers for Multi-Spanning Helical Membrane Proteins. J Chem Inf Model 56:423-34
Sliwoski, Gregory; Mendenhall, Jeffrey; Meiler, Jens (2016) Autocorrelation descriptor improvements for QSAR: 2DA_Sign and 3DA_Sign. J Comput Aided Mol Des 30:209-17
Moretti, Rocco; Bender, Brian J; Allison, Brittany et al. (2016) Rosetta and the Design of Ligand Binding Sites. Methods Mol Biol 1414:47-62
Gallant, Jean-Nicolas; Sheehan, Jonathan H; Shaver, Timothy M et al. (2015) EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to Afatinib. Cancer Discov 5:1155-63
O'Meara, Matthew J; Leaver-Fay, Andrew; Tyka, Michael D et al. (2015) Combined covalent-electrostatic model of hydrogen bonding improves structure prediction with Rosetta. J Chem Theory Comput 11:609-22
Jacobs, Timothy M; Yumerefendi, Hayretin; Kuhlman, Brian et al. (2015) SwiftLib: rapid degenerate-codon-library optimization through dynamic programming. Nucleic Acids Res 43:e34
Der, Bryan S; Kluwe, Christien; Miklos, Aleksandr E et al. (2013) Alternative computational protocols for supercharging protein surfaces for reversible unfolding and retention of stability. PLoS One 8:e64363

Showing the most recent 10 out of 22 publications